Back to Search Start Over

Blood Oxygen, Sleep Disordered Breathing, and Respiratory Instability in Patients With Chronic Heart Failure - PROST Subanalysis.

Authors :
Tobushi T
Kadokami T
Takagawa J
Dohi K
Joho S
Wada O
Momomura SI
Koyama T
Haruki N
Ando SI
Asanoi H
Source :
Circulation reports [Circ Rep] 2019 Sep 28; Vol. 1 (10), pp. 414-421. Date of Electronic Publication: 2019 Sep 28.
Publication Year :
2019

Abstract

Background: Respiratory stability index (RSI), a semi-quantitative measure of respiratory instability, was found to reflect congestive and other clinical status of acutely decompensated heart failure in the PROST study. Given that the association between RSI and another important factors affecting respiration, such as peripheral oxygen saturation (SpO <subscript>2</subscript> ), and the influence of oxygen inhalation on this association were undetermined, and that the association between common sleep-disordered breathing (SDB) parameters and RSI was unknown, we performed a subanalysis using PROST data. Methods and Results: Correlation analyses were performed to evaluate the relationships between RSI, SpO <subscript>2</subscript> , and other SDB parameters (3% oxygen desaturation index [3%ODI], respiratory disturbance index [RDI]) using Spearman's rank correlation. RSI and overnight mean SpO <subscript>2</subscript> were not significantly correlated either after admission (n=38) or before discharge (n=36; r=0.27, P=0.10 and r=0.05, P=0.76, respectively). This correlation was also not affected by presence or absence of oxygen inhalation. 3%ODI, RDI and RSI were significantly and inversely correlated both after admission and before discharge. Conclusions: RSI and blood oxygen level were not significantly correlated irrespective of oxygen inhalation, while the SDB parameters were significantly correlated, suggesting that RSI reflects lung congestion independently of blood oxygen concentration and, thus, can be a useful indicator of the non-invasive assessment of lung congestion.<br />Competing Interests: S.A., H.A. received research funding from Teijin Pharma; S.M. received lecture fee from Teijin Pharma; K.D. received scholarship donation from Merck & Co., Otsuka Pharmaceutical, Daiichi Sankyo and Takeda Pharmaceutical. The other authors declare no conflicts of interest.<br /> (Copyright © 2019, THE JAPANESE CIRCULATION SOCIETY.)

Details

Language :
English
ISSN :
2434-0790
Volume :
1
Issue :
10
Database :
MEDLINE
Journal :
Circulation reports
Publication Type :
Academic Journal
Accession number :
33693078
Full Text :
https://doi.org/10.1253/circrep.CR-19-0068